INVO Fertility (IVF) EBT Growth (1y) (2012 - 2026)
INVO Fertility (IVF) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.94% |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.96% |
| Sep 30, 2025 | -65.14% |
| Jun 30, 2025 | -42.93% |
| Mar 31, 2025 | -991.35% |
| Dec 31, 2024 | -86.51% |
| Sep 30, 2024 | -28.47% |
| Jun 30, 2024 | -0.34% |
| Mar 31, 2024 | 37.49% |
| Dec 31, 2023 | 28.69% |
| Sep 30, 2023 | 51.11% |
| Jun 30, 2023 | 20.11% |
| Mar 31, 2023 | 13.49% |
| Dec 31, 2022 | -2,816.55% |
| Sep 30, 2022 | -2.75% |
| Jun 30, 2022 | -54.13% |
| Mar 31, 2022 | -20.18% |
| Dec 31, 2021 | 102.67% |
| Sep 30, 2021 | -40.04% |
| Jun 30, 2021 | -37.36% |
| Mar 31, 2021 | -69.86% |